125 related articles for article (PubMed ID: 10373682)
41. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
[TBL] [Abstract][Full Text] [Related]
42. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
[TBL] [Abstract][Full Text] [Related]
43. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
44. [Combining clinical investigation with molecular genetics research: to push forward the study of hereditary colorectal carcinoma into a higher level in China].
Li S
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1369-70. PubMed ID: 12613476
[No Abstract] [Full Text] [Related]
45. Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells.
Schwarz VA; Hornung R; Fedier A; Fehr MK; Walt H; Haller U; Fink D
Br J Cancer; 2002 Apr; 86(7):1130-5. PubMed ID: 11953861
[TBL] [Abstract][Full Text] [Related]
46. Meiotic arrest and aneuploidy in MLH3-deficient mice.
Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
[TBL] [Abstract][Full Text] [Related]
47. Screening families with endometrial and colorectal cancers for germline mutations.
Liu T; Chen J; Salahshor S; Kuismanen S; Holmberg E; Grönberg H; Peltomäki P; Lindblom A
J Med Genet; 2001 Sep; 38(9):E29. PubMed ID: 11546830
[No Abstract] [Full Text] [Related]
48. Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer.
Viel A; Novella E; Genuardi M; Capozzi E; Fornasarig M; Pedroni M; Santarosa M; De Leon MP; Della Puppa L; Anti M; Boiocchi M
Int J Oncol; 1998 Sep; 13(3):565-9. PubMed ID: 9683794
[TBL] [Abstract][Full Text] [Related]
49. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
50. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
[TBL] [Abstract][Full Text] [Related]
51. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
[TBL] [Abstract][Full Text] [Related]
52. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
53. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
[TBL] [Abstract][Full Text] [Related]
54. Application of in situ hybridization probes for MLH-1 and MSH-2 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemistry and tumor stage.
Korabiowska M; Cordon-Cardo C; Jaenckel F; Stachura J; Fischer G; Brinck U
Hum Pathol; 2004 Dec; 35(12):1543-8. PubMed ID: 15619215
[TBL] [Abstract][Full Text] [Related]
55. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
[TBL] [Abstract][Full Text] [Related]
56. Autoantibodies to DNA mismatch repair enzymes in polymyositis/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis.
Muro Y; Nakashima R; Hosono Y; Sugiura K; Mimori T; Akiyama M
Arthritis Rheumatol; 2014 Dec; 66(12):3457-62. PubMed ID: 25186186
[TBL] [Abstract][Full Text] [Related]
57. The silence of the genes: matching mismatch repair defects with tumors.
Boland CR; Goel A
Cancer; 2003 Nov; 98(10):2091-4. PubMed ID: 14601077
[No Abstract] [Full Text] [Related]
58. Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt.
Soliman AS; Bondy ML; Guan Y; El-Badawi S; Mokhtar N; Bayomi S; Raouf AA; Ismail S; McPherson RS; Abdel-Hakim TF; Beasley RP; Levin B; Wei Q
Int J Oncol; 1998 Jun; 12(6):1315-9. PubMed ID: 9592192
[TBL] [Abstract][Full Text] [Related]
59. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
[TBL] [Abstract][Full Text] [Related]
60. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
